Skip to main content
Log in

Pharmacological therapy after coronary angioplasty

Early experience with low molecular weight heparin for prophylaxis of reocclusion

  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fleck E, Dacian S, Dirschinger J, Hall D, Rudolph W (1984) Quantitative changes in stenotic coronary artery lesions during follow-up after PTCA. Circulation 70 (supl II):11–176 (abst)

    Google Scholar 

  2. Holmes DR Jr, Vlietstra RE, Smith HC, et al. (1984) Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol 53:Suppl:77C-81C

    PubMed  Google Scholar 

  3. Kaltenbach M, Kober G, Scherer D, Vallbracht C (1985) Recurrence rate after successful coronary angioplasty. Eur Heart J 6:276–281

    PubMed  Google Scholar 

  4. Schwartz L, Bourassa MG, Lesperance J, Aldrige HE, et al. (1988) Aspirin and ipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318:1714–1719

    PubMed  Google Scholar 

  5. Serruys PW, Luijten HE, Beat KJ, Geuskens R, et al. (1988) Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. Circulation 77:361–371

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, T., Tebbe, U., Schrader, J. et al. Pharmacological therapy after coronary angioplasty. Klin Wochenschr 68, 294 (1990). https://doi.org/10.1007/BF02116062

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02116062

Keywords

Navigation